Evicenter
Nucala (mepolizumab) in Severe eosinophilic asthma
Manufacturer
GlaxoSmithKline
Prescribing information
Nucala (opens in a new tab)
Questions
38
Last updated

All questions

Clinical trials: Nucala (mepolizumab) in severe eosinophilic asthma

11 questions · 6 sources

Study results

How much did Nucala reduce severe asthma exacerbations vs placebo (MENSA)?

“Primary endpoint: Exacerbations*/year for NUCALA vs placebo, 0.83 vs 1.74, 53% reduction (P<0.001).” (opens the source at this quote in a new tab)

This passage is in a collapsed section of the page; select: Trial 2: Study design, description, primary endpoint, and baseline characteristics

Note: The HCP site calls MENSA Trial 2. In the label rows, the values after each group are exacerbations per year, then for NUCALA the rate difference and rate ratio (95% CI) versus placebo.

Does Nucala reduce asthma hospitalizations or ER visits vs placebo?

Note: All passages report the 32-week placebo-controlled trial that the HCP site calls Trial 2 (MENSA in the Prescribing Information); the first figure is the secondary endpoint of exacerbations requiring hospitalization or an emergency department visit. Both passages from the HCP site report the full trial population (NUCALA n = 194, placebo n = 191). In the label rows, the values after each group are exacerbations per year, then for NUCALA the rate difference and rate ratio (95% CI) versus placebo.

Does Nucala reduce oral steroid use in severe asthma (SIRIUS)?

Note: The HCP site calls SIRIUS Trial 3.

Does Nucala improve lung function (FEV1) in severe asthma?

Note: In DREAM the dose was mepolizumab 75 mg intravenously (footnote a); the label states that NUCALA is not indicated for intravenous use.

Does Nucala improve asthma control scores vs placebo (MENSA, ACQ-5)?

Does Nucala improve quality of life in severe asthma (SGRQ)?

Note: The first two passages are from MENSA; the others describe MUSCA. SGRQ is the St. George's Respiratory Questionnaire.

Pediatric efficacy

How was Nucala's effectiveness established in children 6 to 11?

Long-term data

What are the long-term side effects of Nucala for severe asthma?

Note: The second and third passages describe COLUMBA, the 4.5-year open-label study.

What was the exacerbation rate in the 4.5-year Nucala open-label study?

What did the 6.4-year Nucala open-label access study show for safety?

What side effects occurred in the 52-week Nucala COSMOS extension study?